Researchers wanted to provide insight into the relative clinical value of Apretude and lenacapavir compared with no ...

Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

SA has accepted an offer of just over R520-million from the Global Fund to Fight Aids, TB and Malaria to buy the twice-a-year ...

The World Health Organization has released new guidelines which, for the first time, recommend the use of an injectable form ...

TANZANIA is among countries expected to benefit from the upcoming rollout of injectable lenacapavir for HIV prevention, following a landmark recommendation by the World Health Organization (WHO).

This isn't about managing the AIDS pandemic. It's about ending it -- and letting a new generation grow and thrive free of its threat.

The World Health Organisation (WHO) has raised concern over the stagnation of global HIV prevention efforts, announcing ...

Lenacapavir, new twice-yearly HIV injection, raises hope for pill-weary patients. Discordant couples, sex workers hail ‘game ...

Lenacapavir has been incredibly promising in trials and now the World Health Organisation have officially recommended the drug for HIV prevention. Smitha Mundasad explains the difference this ...

An investigational once-weekly oral antiretroviral therapy (ART) combination effectively maintained viral suppression in ...

Despite the recent approval of lenacapavir as a twice yearly PrEP, there is still a need for choice in HIV prevention, argue ...